The story of Sildenafil offers a intricate case study for investors eyeing pharma. While initial sales were astounding, recent patent expiry and the emergence of cheaper versions have severely affected revenues. In addition, growing regulatory oversight and pressure to reduce medication prices pose ongoing challenges. Therefore, betting on business

The emergence of so-called "Elite Gambler's The Pill" – often referring to exceptionally high doses prescribed by rogue physicians – represents a troublingly alarming trend. While standard dosages of the medication are intended for treating erectile dysfunction safely in most men, these significantly elevated amounts pose a significant hazard t